Role of lipid peroxidation derived 4-hydroxynonenal (4-HNE) in cancer: Focusing on mitochondria

Redox Biology

Volumn 4, Issue , 2015, Pages 193-199

  Zhong, Huiqin ^a,b,c   Yin, Huiyong ^a,b,c,d  

^a Chinese Academy of Sciences   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c BEIJING HOSPITAL   (China)

^d SHANGHAITECH UNIVERSITY   (China)

Author keywords

4 HNE; Cancer; Cardiolipin; Free radicals; Lipid peroxidation; Mitochondria

Indexed keywords

4 HYDROXYNONENAL; 8 HYDROXYGUANINE; ALDEHYDE DEHYDROGENASE ISOENZYME 2; ANTINEOPLASTIC AGENT; ARSENIC TRIOXIDE; CARDIOLIPIN; DOCOSAHEXAENOIC ACID; DOXORUBICIN; MITOCHONDRIAL DNA; MITOCHONDRIAL PROTEIN; MITOQ; MITOTEMPO; PHOSPHOLIPID; REACTIVE OXYGEN METABOLITE; SCAVENGER; UBIDECARENONE; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN; 4-HYDROXY-2-NONENAL; ALDEHYDE; DNA; FREE RADICAL; TUMOR PROTEIN;

ALCOHOL CONSUMPTION; APOPTOSIS; CANCER GROWTH; CANCER RISK; CARCINOGENESIS; CHEMORADIOTHERAPY; DNA ADDUCT; DNA DAMAGE; DRUG CYTOTOXICITY; HEART DISEASE; HUMAN; KETOGENIC DIET; LIPID PEROXIDATION; LUNG CANCER; METASTASIS; MITOCHONDRIAL ENERGY TRANSFER; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; REVIEW; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOPLASM; PATHOLOGY; SIGNAL TRANSDUCTION;

ALDEHYDES; CARDIOLIPINS; DNA, NEOPLASM; FREE RADICALS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIPID PEROXIDATION; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; NEOPLASM PROTEINS; NEOPLASMS; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

EID: 84921058777     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2014.12.011     Document Type: Review

References (59)

1. Davies K.J. Oxidative stress, antioxidant defenses, and damage removal, repair, and replacement systems. IUBMB Life 2000, 50(4-5):279-289. http://www.ncbi.nlm.nih.gov/pubmed/11327322, 10.1080/713803728.
2. Yin H., Xu L., Porter N.A. Free radical lipid peroxidation: mechanisms and analysis. Chemical Reviews 2011, 111(10):5944-5972. http://www.ncbi.nlm.nih.gov/pubmed/21861450, 10.1021/cr200084z.
3. Benedetti A., Comporti M., Esterbauer H. Identification of 4-hydroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids. Biochimica et Biophysica Acta 1980, 620(2):281-296. http://www.ncbi.nlm.nih.gov/pubmed/6254573, 10.1016/0005-2760(80)90209-X.
4. Shoeb M., Ansari N.H., Srivastava S.K., Ramana K.V. 4-hydroxynonenal in the pathogenesis and progression of human diseases. Current Medicinal Chemistry 2014, 21(2):230-237. http://www.ncbi.nlm.nih.gov/pubmed/23848536, 10.2174/09298673113209990181.
5. West J.D., Marnett L.J. Endogenous reactive intermediates as modulators of cell signaling and cell death. Chemical Research in Toxicology 2006, 19(2):173-194. http://www.ncbi.nlm.nih.gov/pubmed/16485894, 10.1021/tx050321u.
6. Barrera G., Pizzimenti S., Ciamporcero E.S., Daga M., Ullio C., Arcaro A., Cetrangolo G.P., Ferretti C., Dianzani C., Lepore A., et al. Role of 4-hydroxynonenal-protein adducts in human diseases. Antioxidants & Redox Signaling 2014, http://www.ncbi.nlm.nih.gov/pubmed/25365742, 10.1089/ars.2014.6166.
7. Roede J.R., Jones D.P. Reactive species and mitochondrial dysfunction: mechanistic significance of 4-hydroxynonenal. Environmental and Molecular Mutagenesis 2010, 51(5):380-390. http://www.ncbi.nlm.nih.gov/pubmed/20544880, 10.1002/em.20553.
8. Guéraud F., Atalay M., Bresgen N., Cipak A., Eckl P.M., Huc L., Jouanin I., Siems W., Uchida K. Chemistry and biochemistry of lipid peroxidation products. Free Radical Research 2010, 44(10):1098-1124. http://www.ncbi.nlm.nih.gov/pubmed/20836659, 10.3109/10715762.2010.498477.
9. Chen Z.H., Niki E. 4-hydroxynonenal (4-HNE) has been widely accepted as an inducer of oxidative stress. Is this the whole truth about it or can 4-HNE also exert protective effects?. IUBMB Life 2006, 58(5-6):372-373. http://www.ncbi.nlm.nih.gov/pubmed/16754333, 10.1080/15216540600686896.
10. Aldini G., Carini M., Yeum K.-J., Vistoli G. Novel molecular approaches for improving enzymatic and nonenzymatic detoxification of 4-hydroxynonenal: toward the discovery of a novel class of bioactive compounds. Free Radical Biology and Medicine 2014, 69(0):145-156. http://www.ncbi.nlm.nih.gov/pubmed/24456906, 10.1016/j.freeradbiomed.2014.01.017.
11. Levonen A.-L., Hill B.G., Kansanen E., Zhang J., Darley-Usmar V.M. Redox regulation of antioxidants, autophagy, and the response to stress: implications for electrophile therapeutics. Free Radical Biology and Medicine 2014, 71(0):196-207. http://www.ncbi.nlm.nih.gov/pubmed/24681256, 10.1016/j.freeradbiomed.2014.03.025.
12. Liu W., Porter N.A., Schneider C., Brash A.R., Yin H. Formation of 4-hydroxynonenal from cardiolipin oxidation: intramolecular peroxyl radical addition and decomposition. Free Radical Biology and Medicine 2011, 50(1):166-178. http://www.ncbi.nlm.nih.gov/pubmed/21047551, 10.1016/j.freeradbiomed.2010.10.709.
13. Zhong H., Lu J., Xia L., Zhu M., Yin H. Formation of electrophilic oxidation products from mitochondrial cardiolipin in vitro and in vivo in the context of apoptosis and atherosclerosis. Redox Biology 2014, 2(0):878-883. http://www.ncbi.nlm.nih.gov/pubmed/25061570, 10.1016/j.redox.2014.04.003.
14. Bellot G.L., Liu D., Pervaiz S. ROS, autophagy, mitochondria and cancer: Ras, the hidden master?. Mitochondrion 2013, 13(3):155-162. http://www.ncbi.nlm.nih.gov/pubmed/22750269, 10.1016/j.mito.2012.06.007.
15. DeNicola G.M., Karreth F.A., Humpton T.J., Gopinathan A., Wei C., Frese K., Mangal D., Yu K.H., Yeo C.J., Calhoun E.S., et al. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 2011, 475(7354):106-109. http://www.ncbi.nlm.nih.gov/pubmed/21734707, 10.1038/nature10189.
16. Ma Y., Zhang L., Rong S., Qu H., Zhang Y., Chang D., Pan H., Wang W. Relation between gastric cancer and protein oxidation, DNA damage, and lipid peroxidation. Oxidative Medicine and Cellular Longevity 2013, 2013:543760. http://www.ncbi.nlm.nih.gov/pubmed/24454985, 10.1155/2013/543760.
17. Baradat M., Jouanin I., Dalleau S., Taché S., Gieules M., Debrauwer L., Canlet C., Huc L., Dupuy J., Pierre F.H., et al. 4-hydroxy-2(E)-nonenal metabolism differs in Apc(+/+) cells and in Apc(Min/+) cells: it may explain colon cancer promotion by heme iron. Chemical Research in Toxicology 2011, 24(11):1984-1993. http://www.ncbi.nlm.nih.gov/pubmed/21967605, 10.1021/tx2003036.
18. Schneider C., Porter N.A., Brash A.R. Routes to 4-hydroxynonenal: fundamental issues in the mechanisms of lipid peroxidation. Journal of Biological Chemistry 2008, 283(23):15539-15543. http://www.ncbi.nlm.nih.gov/pubmed/18285327, 10.1074/jbc.R800001200.
19. Schneider C., Tallman K.A., Porter N.A., Brash A.R. Two distinct pathways of formation of 4-hydroxynonenal. Mechanisms of nonenzymatic transformation of the 9- and 13-hydroperoxides of linoleic acid to 4-hydroxyalkenals. Journal of Biological Chemistry 2001, 276(24):20831-20838. http://www.ncbi.nlm.nih.gov/pubmed/11259420, 10.1074/jbc.M101821200.
20. Yin H., Zhu M. Free radical oxidation of cardiolipin: chemical mechanisms, detection and implication in apoptosis, mitochondrial dysfunction and human diseases. Free Radical Research 2012, 46(8):959-974. http://www.ncbi.nlm.nih.gov/pubmed/22468920, 10.3109/10715762.2012.676642.
21. Zhong H., Lu J., Xia L., Zhu M., Yin H. Formation of electrophilic oxidation products from mitochondrial cardiolipin in vitro and in vivo in the context of apoptosis and atherosclerosis. Redox Biology 2014, 2:878-883. http://www.ncbi.nlm.nih.gov/pubmed/25061570, 10.1016/j.redox.2014.04.003.
22. Liu W., Porter N.A., Schneider C., Brash A.R., Yin H. Formation of 4-hydroxynonenal from cardiolipin oxidation: intramolecular peroxyl radical addition and decomposition. Free Radical Biology and Medicine 2011, 50(1):166-178. http://www.ncbi.nlm.nih.gov/pubmed/21047551, 10.1016/j.freeradbiomed.2010.10.709.
23. Gonzalvez F., Gottlieb E. Cardiolipin: setting the beat of apoptosis. Apoptosis: An International Journal on Programmed Cell Death 2007, 12(5):877-885. http://www.ncbi.nlm.nih.gov/pubmed/17294083, 10.1007/s10495-007-0718-8.
24. Oberley T.D., Toyokuni S., Szweda L.I. Localization of hydroxynonenal protein adducts in normal human kidney and selected human kidney cancers. Free Radical Biology and Medicine 1999, 27(5-6):695-703. http://www.ncbi.nlm.nih.gov/pubmed/10490290, 10.1016/S0891-5849(99)00117-3.
25. Zhao Y., Miriyala S., Miao L., Mitov M., Schnell D., Dhar S.K., Cai J., Klein J.B., Sultana R., Butterfield D.A., et al. Redox proteomic identification of HNE-bound mitochondrial proteins in cardiac tissues reveals a systemic effect on energy metabolism after doxorubicin treatment. Free Radical Biology and Medicine 2014, 72:55-65. http://www.ncbi.nlm.nih.gov/pubmed/24632380, 10.1016/j.freeradbiomed.2014.03.001.
26. Poli G., Schaur R.J., Siems W.G., Leonarduzzi G. 4-Hydroxynonenal: a membrane lipid oxidation product of medicinal interest. Medicinal Research Reviews 2008, 28(4):569-631. http://www.ncbi.nlm.nih.gov/pubmed/18058921, 10.1002/med.20117.
27. Siems W., Grune T. Intracellular metabolism of 4-hydroxynonenal. Molecular Aspects of Medicine 2003, 24(4-5):167-175. http://www.ncbi.nlm.nih.gov/pubmed/12892994, 10.1016/S0098-2997(03)00011-6.
28. Chang B., Nishikawa M., Nishiguchi S., Inoue M. l-Carnitine inhibits hepatocarcinogenesis via protection of mitochondria. International Journal of Cancer 2005, 113(5):719-729. http://www.ncbi.nlm.nih.gov/pubmed/15499623, 10.1002/ijc.20636.
29. Leake K., Singhal J., Nagaprashantha L.D., Awasthi S., Singhal S.S. RLIP76 regulates PI3K/Akt signaling and chemo-radiotherapy resistance in pancreatic cancer. PLOS One 2012, 7(4):e34582. http://www.ncbi.nlm.nih.gov/pubmed/22509328, 10.1371/journal.pone.0034582.
30. Kansanen E., Kuosmanen S.M., Leinonen H., Levonen A.-L. The Keap1-Nrf2 pathway: mechanisms of activation and dysregulation in cancer. Redox Biology 2013, 1(1):45-49. http://www.ncbi.nlm.nih.gov/pubmed/24024136, 10.1016/j.redox.2012.10.001.
31. +/NADH balance regulate breast cancer progression. Journal of Clinical Investigation 2013, 123(3):1068-1081. http://www.ncbi.nlm.nih.gov/pubmed/23426180, 10.1172/JCI64264.
32. Porporato P.E., Payen V.L., Pérez-Escuredo J., De Saedeleer C.J., Danhier P., Copetti T., Dhup S., Tardy M., Vazeille T., Bouzin C., et al. A mitochondrial switch promotes tumor metastasis. Cell Report 2014, 8(3):754-766. http://www.ncbi.nlm.nih.gov/pubmed/25066121, 10.1016/j.celrep.2014.06.043.
33. Dröse S., Zwicker K., Brandt U. Full recovery of the NADH:ubiquinone activity of complex I (NADH:ubiquinone oxidoreductase) from Yarrowia lipolytica by the addition of phospholipids. Biochimica et Biophysica Acta 2002, 1556(1):65-72. http://www.ncbi.nlm.nih.gov/pubmed/12351219, 10.1016/S0005-2728(02)00307-9.
34. Fry M., Green D.E. Cardiolipin requirement for electron transfer in complex I and III of the mitochondrial respiratory chain. Journal ofBiological Chemistry 1981, 256(4):1874-1880. http://www.ncbi.nlm.nih.gov/pubmed/6257690.
35. Eble K.S., Coleman W.B., Hantgan R.R., Cunningham C.C. Tightly associated cardiolipin in the bovine heart mitochondrial ATP synthase as analyzed by 31P nuclear magnetic resonance spectroscopy. Journal ofBiological Chemistry 1990, 265(32):19434-19440. http://www.ncbi.nlm.nih.gov/pubmed/2147180.
36. Valle A., Oliver J., Roca P. Role of uncoupling proteins in cancer. Cancers (Basel) 2010, 2(2):567-591. http://www.ncbi.nlm.nih.gov/pubmed/24281083, 10.3390/cancers2020567.
37. Echtay K.S., Murphy M.P., Smith R.A., Talbot D.A., Brand M.D. Superoxide activates mitochondrial uncoupling protein 2 from the matrix side. Studies using targeted antioxidants. Journal ofBiological Chemistry 2002, 277(49):47129-47135. http://www.ncbi.nlm.nih.gov/pubmed/12372827, 10.1074/jbc.M208262200.
38. Krauss S., Zhang C.-Y., Scorrano L., Dalgaard L.T., St-Pierre J., Grey S.T., Lowell B.B. Superoxide-mediated activation of uncoupling protein 2 causes pancreatic beta cell dysfunction. Journal of Clinical Investigation 2003, 112(12):1831-1842. http://www.ncbi.nlm.nih.gov/pubmed/14679178, 10.1172/JCI19774.
39. Esteves T.C., Brand M.D. The reactions catalysed by the mitochondrial uncoupling proteins UCP2 and UCP3. Biochimica et Biophysica Acta 2005, 1709(1):35-44. http://www.ncbi.nlm.nih.gov/pubmed/16005426, 10.1016/j.bbabio.2005.06.002.
40. Echtay K.S., Esteves T.C., Pakay J.L., Jekabsons M.B., Lambert A.J., Portero-Otín M., Pamplona R., Vidal-Puig A.J., Wang S., Roebuck S.J., Brand M.D. A signalling role for 4-hydroxy-2-nonenal in regulation of mitochondrial uncoupling. EMBO Journal 2003, 22(16):4103-4110. http://www.ncbi.nlm.nih.gov/pubmed/12912909, 10.1093/emboj/cdg412.
41. Yoval-Sánchez B., Rodríguez-Zavala J.S. Differences in susceptibility to inactivation of human aldehyde dehydrogenases by lipid peroxidation byproducts. Chemical Research in Toxicology 2012, 25(3):722-729. http://www.ncbi.nlm.nih.gov/pubmed/22339434, 10.1021/tx2005184.
42. Asakage T., Yokoyama A., Haneda T., Yamazaki M., Muto M., Yokoyama T., Kato H., Igaki H., Tsujinaka T., Kumagai Y., et al. Genetic polymorphisms of alcohol and aldehyde dehydrogenases, and drinking, smoking and diet in Japanese men with oral and pharyngeal squamous cell carcinoma. Carcinogenesis 2007, 28(4):865-874. http://www.ncbi.nlm.nih.gov/pubmed/17071628, 10.1093/carcin/bgl206.
43. Ding J.-H., Li S.P., Cao H.X., Wu J.Z., Gao C.M., Su P., Liu Y.T., Zhou J.N., Chang J., Yao G.H. Polymorphisms of alcohol dehydrogenase-2 and aldehyde dehydrogenase-2 and esophageal cancer risk in Southeast Chinese males. World Journal of Gastroenterology 2009, 15(19):2395-2400. http://www.ncbi.nlm.nih.gov/pubmed/19452585, 10.3748/wjg.15.2395.
44. Muto M., Takahashi M., Ohtsu A., Ebihara S., Yoshida S., Esumi H. Risk of multiple squamous cell carcinomas both in the esophagus and the head and neck region. Carcinogenesis 2005, 26(5):1008-1012. http://www.ncbi.nlm.nih.gov/pubmed/15718256, 10.1093/carcin/bgi035.
45. Pawlosky R.J., Salem N. Perspectives on alcohol consumption: liver polyunsaturated fatty acids and essential fatty acid metabolism. Alcohol 2004, 34(1):27-33. http://www.ncbi.nlm.nih.gov/pubmed/15670662, 10.1016/j.alcohol.2004.07.009.
46. Niemelä O. Distribution of ethanol-induced protein adducts in vivo: relationship to tissue injury. Free Radical Biology and Medicine 2001, 31(12):1533-1538. http://www.ncbi.nlm.nih.gov/pubmed/11744326, 10.1016/S0891-5849(01)00744-4.
47. Doorn J.A., Hurley T.D., Petersen D.R. Inhibition of human mitochondrial aldehyde dehydrogenase by 4-Hydroxynon-2-enal and 4-Oxonon-2-enal. Chem. Res. Toxicol. 2006, 19(1):102-110. http://www.ncbi.nlm.nih.gov/pubmed/16411662, 10.1021/tx0501839.
48. Lee C.H., Wu S.B., Hong C.H., Chen G.S., Wei Y.H., Yu H.S. Involvement of mtDNA damage elicited by oxidative stress in the arsenical skin cancers. J. Invest. Dermatol. 2013, 133(7):1890-1900. http://www.ncbi.nlm.nih.gov/pubmed/23370535, 10.1038/jid.2013.55.
49. Ma W.W., Hou C.C., Zhou X., Yu H.L., Xi Y.D., Ding J., Zhao X., Xiao R. Genistein alleviates the mitochondria-targeted DNA damage induced by beta-amyloid peptides 25-35 in C6 glioma cells. Neurochem. Res. 2013, 38(7):1315-1323. http://www.ncbi.nlm.nih.gov/pubmed/23519932, 10.1007/s11064-013-1019-y.
50. Wada T., Tanji N., Ozawa A., Wang J., Shimamoto K., Sakayama K., Yokoyama M. Mitochondrial DNA mutations and 8-hydroxy-2'-deoxyguanosine content in Japanese patients with urinary bladder and renal cancers. Anticancer Research 2006, 26(5A):3403-3408. http://www.ncbi.nlm.nih.gov/pubmed/17094459.
51. Hu W., Feng Z., Eveleigh J., Iyer G., Pan J., Amin S., Chung F.L., Tang M.S. The major lipid peroxidation product, trans-4-hydroxy-2-nonenal, preferentially forms DNA adducts at codon 249 of human p53 gene, a unique mutational hotspot in hepatocellular carcinoma. Carcinogenesis 2002, 23(11):1781-1789. http://www.ncbi.nlm.nih.gov/pubmed/12419825, 10.1093/carcin/23.11.1781.
52. Daum G., Vance J.E. Import of lipids into mitochondria. Progress in Lipid Research 1997, 36(2-3):103-130. http://www.ncbi.nlm.nih.gov/pubmed/9624424.
53. Guichardant M., Bacot S., Molière P., Lagarde M. Hydroxy-alkenals from the peroxidation of n-3 and n-6 fatty acids and urinary metabolites. Prostaglandins, Leukotrienes and Essential Fatty Acids 2006, 75(3):179-182. http://www.ncbi.nlm.nih.gov/pubmed/16828271, 10.1016/j.plefa.2006.05.006.
54. Bacot S., Bernoud-Hubac N., Chantegrel B., Deshayes C., Doutheau A., Ponsin G., Lagarde M., Guichardant M. Evidence for in situ ethanolamine phospholipid adducts with hydroxy-alkenals. Journal of Lipid Research 2007, 48(4):816-825. http://www.ncbi.nlm.nih.gov/pubmed/17220481, 10.1194/jlr.M600340-JLR200.
55. Guichardant M., Bernoud-Hubac N., Chantegrel B., Deshayes C., Lagarde M. Aldehydes from n-6 fatty acid peroxidation. Effects on aminophospholipids. Prostaglandins, Leukotrienes and Essential Fatty Acids 2002, 67(2-3):147-149. http://www.ncbi.nlm.nih.gov/pubmed/12324234, 10.1054/plef.2002.0412.
56. Rogers C., Davis B., Neufer P.D., Murphy M.P., Anderson E.J., Robidoux J. A transient increase in lipid peroxidation primes preadipocytes for delayed mitochondrial inner membrane permeabilization and ATP depletion during prolonged exposure to fatty acids. Free Radical Biology and Medicine 2014, 67:330-341. 10.1016/j.freeradbiomed.2013.11.012.
57. Jin H., Kanthasamy A., Ghosh A., Anantharam V., Kalyanaraman B., Kanthasamy A.G. Mitochondria-targeted antioxidants for treatment of Parkinson's disease: preclinical and clinical outcomes. Biochimica et Biophysica Acta 2014, 1842(8):1282-1294. http://www.ncbi.nlm.nih.gov/pubmed/24060637, 10.1016/j.bbadis.2013.09.007.
58. Baumgartner M., Sturlan S., Roth E., Wessner B., Bachleitner-Hofmann T. Enhancement of arsenic trioxide-mediated apoptosis using docosahexaenoic acid in arsenic trioxide-resistant solid tumor cells. International Journal of Cancer 2004, 112(4):707-712. http://www.ncbi.nlm.nih.gov/pubmed/15382055, 10.1002/ijc.20462.
59. Allen B.G., Bhatia S.K., Buatti J.M., Brandt K.E., Lindholm K.E., Button A.M., Szweda L.I., Smith B.J., Spitz D.R., Fath M.A. Ketogenic diets enhance oxidative stress and radio-chemo-therapy responses in lung cancer xenografts. Clinical Cancer Research 2013, 19(14):3905-3913. http://www.ncbi.nlm.nih.gov/pubmed/23743570, 10.1158/1078-0432.CCR-12-0287.